Observational studyFrontiers in endocrinology2026
An ultrasonographic tumor location-based model for predicting central lymph node metastasis in unifocal papillary thyroid microcarcinoma.
Observational study in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Risk factors for central lymph node metastasis in papillary thyroid microcarcinoma: a simplified risk scoring system.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Accurate preoperative assessment of central lymph node metastasis (CLNM) in patients with unifocal papillary thyroid microcarcinoma (PTMC) remains challenging. This study aimed to develop and validate a nomogram integrating tumor spatial location with clinical and ultrasonographic features for predicting central lymph node metastasis (CLNM). Methods: In this retrospective study, 432 patients with surgically confirmed unifocal PTMC were enrolled. Independent predictors were identified through univariate and multivariate regression, and a nomogram was constructed and internally validated. Results: Age ≤38 years, tumor diameter >0.95 cm, microcalcifications, suspicious central/lateral lymph nodes, tumor in the isthmus, and tumor in the middle/inferior pole adjacent to the posterior capsule were independent risk factors for CLNM, while Hashimoto's thyroiditis was protective. The nomogram showed good discrimination, with AUCs of 0.772 (training) and 0.728 (validation). Calibration and decision curve analysis confirmed clinical utility. Conclusion: The spatial location-based nomogram provides an effective preoperative tool for quantifying CLNM risk, assisting in individualized surgical planning and reducing overtreatment in unifocal PTMC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.